BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15640505)

  • 21. The use of molecular markers as a method to predict the response to neoadjuvant therapy for advanced stage rectal adenocarcinoma.
    Edden Y; Wexner SD; Berho M
    Colorectal Dis; 2012 May; 14(5):555-61. PubMed ID: 21689364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can a biomarker-based scoring system predict pathologic complete response after preoperative chemoradiotherapy for rectal cancer?
    Hur H; Kim NK; Min BS; Baik SH; Lee KY; Koom WS; Ahn JB; Kim H
    Dis Colon Rectum; 2014 May; 57(5):592-601. PubMed ID: 24819099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Downregulation of ATP-binding cassette subfamily C member 4 increases sensitivity to neoadjuvant radiotherapy for locally advanced rectal carcinoma.
    Yu ZQ; Zhang C; Wang H; Lao XY; Chai R; Gao XH; Cao GW; Fu CG
    Dis Colon Rectum; 2013 May; 56(5):600-8. PubMed ID: 23575399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immediate results of combined therapy for local recurrences of rectal cancer].
    Korytova LI; Sandalevskaya AG; Krasnikoval VG; Korytov OV; Meshechkin AV
    Vopr Onkol; 2015; 61(1):52-6. PubMed ID: 26016146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phosphatidylinositol 3-kinase CB association with preoperative radiotherapy response in rectal adenocarcinoma.
    Yu WD; Peng YF; Pan HD; Wang L; Li K; Gu J
    World J Gastroenterol; 2014 Nov; 20(43):16258-67. PubMed ID: 25473181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alteration of DNA ploidy status and cell proliferation induced by preoperative radiotherapy is a prognostic factor in rectal cancer.
    Lammering G; Taher MM; Gruenagel HH; Borchard F; Porschen R
    Clin Cancer Res; 2000 Aug; 6(8):3215-21. PubMed ID: 10955806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased tumor cell proliferation as an indicator of the effect of preoperative radiotherapy of rectal cancer.
    Adell G; Zhang H; Jansson A; Sun XF; Stål O; Nordenskjöld B
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):659-63. PubMed ID: 11395233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apoptosis in rectal carcinoma: prognosis and recurrence after preoperative radiotherapy.
    Adell GC; Zhang H; Evertsson S; Sun XF; Stål OH; Nordenskjöld BA
    Cancer; 2001 May; 91(10):1870-5. PubMed ID: 11346868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preoperative radiotherapy (RT) for rectal cancer: predictive factors of tumor downstaging and residual tumor cell density (RTCD): prognostic implications.
    Berger C; de Muret A; Garaud P; Chapet S; Bourlier P; Reynaud-Bougnoux A; Dorval E; de Calan L; Huten N; le Folch O; Calais G
    Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):619-27. PubMed ID: 9112461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic markers predictive of response to induction chemoradiotherapy for locally advanced rectal cancers.
    Kudrimoti M; Lee EY; Kang Y; Ahmed M; Mohiuddin M
    J Ky Med Assoc; 2007 Jan; 105(1):18-22. PubMed ID: 17310874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p53 immunohistochemical staining predicts residual disease after chemoradiation in patients with high-risk rectal cancer.
    Spitz FR; Giacco GG; Hess K; Larry L; Rich TA; Janjan N; Cleary KR; Skibber JM
    Clin Cancer Res; 1997 Oct; 3(10):1685-90. PubMed ID: 9815551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tissue microarray molecular profiling of early, node-negative adenocarcinoma of the rectum: a comprehensive analysis.
    Hoos A; Nissan A; Stojadinovic A; Shia J; Hedvat CV; Leung DH; Paty PB; Klimstra D; Cordon-Cardo C; Wong WD
    Clin Cancer Res; 2002 Dec; 8(12):3841-9. PubMed ID: 12473598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conformal preoperative endorectal brachytherapy treatment for locally advanced rectal cancer: early results of a phase I/II study.
    Vuong T; Belliveau PJ; Michel RP; Moftah BA; Parent J; Trudel JL; Reinhold C; Souhami L
    Dis Colon Rectum; 2002 Nov; 45(11):1486-93; discussion 1493-5. PubMed ID: 12432296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjuvant radiation therapy for rectal carcinoma: predictors of outcome.
    Myerson RJ; Michalski JM; King ML; Birnbaum E; Fleshman J; Fry R; Kodner I; Lacey D; Lockett MA
    Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):41-50. PubMed ID: 7721638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic Value of Immunohistochemical Markers for Locally Advanced Rectal Cancer.
    Taha A; Taha-Mehlitz S; Petzold S; Achinovich SL; Zinovkin D; Enodien B; Pranjol MZI; Nadyrov EA
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35163861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p53 status: an indicator for the effect of preoperative radiotherapy of rectal cancer.
    Adell G; Sun XF; Stål O; Klintenberg C; Sjödahl R; Nordenskjöld B
    Radiother Oncol; 1999 May; 51(2):169-74. PubMed ID: 10435809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A haplotype of the methylenetetrahydrofolate reductase gene predicts poor tumor response in rectal cancer patients receiving preoperative chemoradiation.
    Terrazzino S; Agostini M; Pucciarelli S; Pasetto LM; Friso ML; Ambrosi A; Lisi V; Leon A; Lise M; Nitti D
    Pharmacogenet Genomics; 2006 Nov; 16(11):817-24. PubMed ID: 17047490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intraoperative radiation therapy for curatively resected rectal cancer.
    Sadahiro S; Suzuki T; Ishikawa K; Yasuda S; Tajima T; Makuuchi H; Murayama C; Ohizumi Y
    Dis Colon Rectum; 2001 Nov; 44(11):1689-95. PubMed ID: 11711743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p53, deleted in colorectal cancer gene, and thymidylate synthase as predictors of histopathologic response and survival in low, locally advanced rectal cancer treated with preoperative adjuvant therapy.
    Saw RP; Morgan M; Koorey D; Painter D; Findlay M; Stevens G; Clarke S; Chapuis P; Solomon MJ
    Dis Colon Rectum; 2003 Feb; 46(2):192-202. PubMed ID: 12576893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic factors for disease-free survival in patients with T3-4 or N+ rectal cancer treated with preoperative chemoradiation therapy, surgery, and intraoperative irradiation.
    Díaz-González JA; Calvo FA; Cortés J; García-Sabrido JL; Gómez-Espí M; Del Valle E; Muñoz-Jiménez F; Alvarez E
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1122-8. PubMed ID: 16406393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.